In summary, for the first time, our data demonstrate sevoflurane inhibits cell proliferation, migration and invasion and induces cell cycle arrest and apoptosis in ovarian cancer cells through targeting STC1. The gene discussed is STC1; the disease is ovarian carcinoma.